CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
85 hedge funds and large institutions have $668M invested in Crescent Biopharma, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.
Holders
85
Holders Change
+1
Holders Change %
+1.19%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
31
Reduced
25
Closed
10
Calls
$1.53M
Puts
$1.23M
Net Calls
+$304K
Net Calls Change
-$215K
Top Buyers
1 |
O
1
OppenheimerFunds
New York
|
$63.7M |
2 |
2
Dimensional Fund Advisors
Austin,
Texas
|
$5.6M |
3 |
3
Man Group
London,
United Kingdom
|
$5.93M |
4 |
JG
4
Jefferies Group
New York
|
$2.46M |
5 |
5
Axa
Paris,
France
|
$10.5M |